ADCendo is Drug Discovery in Denmark that focus on breast cancer business. Founded in 2017. They cover business area such as developer, antibody-drug conjugate, adcs, an approach, target therapy, several cancer form, expression, osteosarcoma, glioblastoma multiforme, GBM, triple-negative breast cancer, doctor, patient, disease, carcinoma, colon, prostate.
2017
( 7 years old in 2024 )
Breast Cancer
-
Copenhagen
Denmark
Private
developerantibody-drug conjugateadcsan approachtarget therapyseveral cancer formexpressionosteosarcomaglioblastoma multiformeGBMtriple-negative breast cancerdoctorpatientdiseasecarcinomacolonprostate
* We use standard office opening hours in near ADCendo's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ADCendo is Drug Discovery business from Denmark that founded in 2017 (7 years old in 2024), ADCendo business is focusing on Breast Cancer.
ADCendo headquarter office and corporate office address is located in Copenhagen Denmark.
ADCendo was founded in Denmark.
In 2024, ADCendo is currently focus on breast cancer sector.
Above is snippet of Google Trends for "breast cancer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ADCendo, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
